Logo-bi
Original Research
Bahman Yousefi, Masoud Darabi*, Behzad Baradaran, Mahmoud Shekari Khaniani, Mohammad Rahbani, Maryam Darabi, Shabnam Fayezi, Amir Mehdizadeh, Negar Saliani, Maghsod Shaaker
Bioimpacts. 2012;2(3): 145-150. doi: 10.5681/bi.2012.019
PMCID: PMC3648933     PMID: 23678452     Scopus ID: 84876717030    
PDF
XML
Cited By:
Original Research
Yalda RahbarSaadat, Nazli Saeidi, Sepideh Zununi Vahed, Abolfazl Barzegari*, Jaleh Barar ORCID
Bioimpacts. 2015;5(1): 25-28. doi: 10.15171/bi.2015.01
PMCID: PMC4401164     PMID: 25901294     Scopus ID: 84924904679    
Original Research
Abbas Asoudeh-Fard, Abolfazl Barzegari, Alireza Dehnad, Sepideh Bastani, Asal Golchin, Yadollah Omidi* ORCID
Bioimpacts. 2017;7(3): 193-198. doi: 10.15171/bi.2017.22
PMCID: PMC5684510     PMID: 29159146     Scopus ID: 85032022290    
Original Research
Majid Gholipour* ORCID, Arezoo Tabrizi ORCID
Bioimpacts. 2020;10(4): 251-257. doi: 10.34172/bi.2020.32
PMCID: PMC7502907     PMID: 32983941     Scopus ID: 85092016587    
Increased MAP4K1 expression did not influence Lats1 activation. The exercise training protocol suppressed Mst1 and Lats1 (Hippo pathway) and caused an increase in Yap1 expression level, which led to physiological cardiac hypertrophy in healthy rats.
Original Research
Aynur Karadağ Gürel* ORCID, Selçuk Gürel ORCID
BioImpacts. 2022;12(2): 89-105. doi: 10.34172/bi.2022.23467
PMCID: PMC8905584     PMID: 35411297     Scopus ID: 85127154960    
As a result, it suggests that the enriched genes and new pathways emerging as a result of the analysis may help identify the group that responds poorly to treatment and the outcome of the treatment.
Original Article
Sanya Haiaty ORCID, Mohammad-Reza Rashidi, Maryam Akbarzadeh, Ahad Bazmany, Mostafa Mostafazadeh, Saba Nikanfar, Roya Shabkhizan, Rostam Rezaeian, Reza Rahbarghazi* ORCID, Mohammad Nouri
Bioimpacts. 2023;13(5): 405-413. doi: 10.34172/bi.2022.24208
PMCID: PMC10509738     PMID: 37736340     Scopus ID: 85172786250    
Original Article
Yuri Yu. Shchegolev ORCID, Danila V. Sorokin, Alexander M. Scherbakov* ORCID, Olga E. Andreeva ORCID, Diana I. Salnikova ORCID, Ekaterina I. Mikhaevich ORCID, Margarita V. Gudkova ORCID, Mikhail A. Krasil’nikov ORCID
Bioimpacts. 2023;13(4): 313-321. doi: 10.34172/bi.2023.27490
PMCID: PMC10460766     PMID: 37645026     Scopus ID: 85168127787    
Prolonged cell treatment with mTOR inhibitor rapamycin leads to the development of resistance. Exosomes of resistant cells induce the resistance to rapamycin in the parent MCF-7cells. Exosome-induced resistance reproduces the changes revealed in the rapamycin-resistant cells, including the activation of ERK/AP-1.
Original Article
Farzaneh Bilan ORCID, Mohammad Amini, Mohammad Amin Doustvandi, Maryam Tohidast, Amir Baghbanzadeh, Seyed Samad Hosseini ORCID, Ahad Mokhtarzadeh* ORCID, Behzad Baradaran*
Bioimpacts. 2024;14(2): 27764. doi: 10.34172/bi.2023.27764
PMCID: PMC10945301     PMID: 38505672    
PDF
XML
Cited By:
Review
Naeimeh Akbari-Gharalari ORCID, Sina Khodakarimi, Farshad Nezhadshahmohammad, Mohammad Karimipour, Abbas Ebrahimi-Kalan* ORCID, Jiagian Wu
Bioimpacts. 2024;14(5): 30153. doi: 10.34172/bi.2023.30153
PMCID: PMC11406431     PMID: 39296798    
PDF
XML
Cited By:


As a peer-reviewed international open-access journal, BioImpacts publishes articles on basic and translational aspects of pharmaceutical and biomedical sciences. 
Acceptance rate: 24% 
Publication fee: Free of charge